Rehana Z Hussain Selected Research

Ligands

3/2004	Ligands for the peroxisome proliferator-activated receptor-gamma and the retinoid X receptor exert additive anti-inflammatory effects on experimental autoimmune encephalomyelitis.
3/2002	Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rehana Z Hussain Research Topics

Disease

14	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 03/2002
12	Multiple Sclerosis 01/2022 - 03/2002
4	Autoimmune Diseases (Autoimmune Disease) 10/2011 - 05/2004
2	Disease Susceptibility (Diathesis) 12/2018 - 06/2011
1	Inflammation (Inflammations) 01/2019
1	Virus Diseases (Viral Diseases) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2011
1	Disease Progression 02/2007
1	Mumps 09/2006
1	Hypertriglyceridemia 05/2004
1	Demyelinating Diseases (Demyelinating Disease) 03/2004
1	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 05/2003

Drug/Important Bio-Agent (IBA)

3	Small Interfering RNA (siRNA)IBA 04/2010 - 11/2004
2	Interleukin-17 (Interleukin 17)IBA 06/2011 - 02/2007
2	PPAR alphaIBA 04/2009 - 05/2004
2	AntigensIBA 09/2006 - 11/2004
2	PPAR-gamma AgonistsIBA 03/2004 - 03/2002
2	LigandsIBA 03/2004 - 03/2002
2	PPAR gammaIBA 03/2004 - 03/2002
2	Protein Tyrosine PhosphatasesIBA 05/2003 - 05/2002
1	Monoclonal AntibodiesIBA 01/2021
1	Natalizumab (Tysabri)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2019
1	Poly I-CIBA 12/2018
1	Interferon Type IIBA 12/2018
1	Amyloid beta-PeptidesIBA 01/2017
1	laquinimodIBA 01/2017
1	Glatiramer Acetate (Copaxone)FDA Link 11/2014
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2014
1	Interleukin-23 (Interleukin 23)IBA 10/2011
1	FumaratesIBA 10/2011
1	Interleukin-12 (IL 12)IBA 10/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 06/2011
1	Proteins (Proteins, Gene)FDA Link 04/2010
1	Prion ProteinsIBA 02/2010
1	RNA (Ribonucleic Acid)IBA 02/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2010
1	Myelin Basic ProteinIBA 02/2007
1	Pathogen-Associated Molecular Pattern MoleculesIBA 03/2006
1	Antisense OligonucleotidesIBA 11/2004
1	OligonucleotidesIBA 11/2004
1	Biological ProductsIBA 11/2004
1	Gemfibrozil (Lopid)FDA LinkGeneric 05/2004
1	ciprofibrateIBA 05/2004
1	Fenofibrate (CiL)FDA LinkGeneric 05/2004
1	Retinoid X Receptors (Retinoid X Receptor)IBA 03/2004
1	Tyrosine (L-Tyrosine)FDA Link 05/2002
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 05/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2004
1	Drug Therapy (Chemotherapy) 01/2021
1	Oral Administration 05/2004